US5985249A
(en)
|
1990-03-22 |
1999-11-16 |
Ultradent Products, Inc. |
Sticky dental compositions for adhering a passive-type dental tray over a person's teeth
|
US6036943A
(en)
|
1990-03-22 |
2000-03-14 |
Ultradent Products, Inc. |
Methods for treating a person's teeth using sticky dental compositions in combination with passive-type dental trays
|
US5571533A
(en)
*
|
1992-02-07 |
1996-11-05 |
Recordati, S.A., Chemical And Pharmaceutical Company |
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
|
DK0797988T3
(da)
|
1993-07-19 |
2009-05-11 |
Univ British Columbia |
Anti-angiogene præparater og fremgangsmåder til anvendelse deraf
|
US5744155A
(en)
*
|
1993-08-13 |
1998-04-28 |
Friedman; Doron |
Bioadhesive emulsion preparations for enhanced drug delivery
|
DE4404011A1
(de)
*
|
1994-02-09 |
1995-08-10 |
Jenapharm Gmbh |
Neue, adhäsiv wirkende Zubereitungen für mit Flüssigkeit benetzte Oberflächen, Verfahren und Vorrichtung zur Erfassung der Adhäsionszeit diesbezüglicher Zubereitungen
|
TW438601B
(en)
*
|
1994-05-18 |
2001-06-07 |
Janssen Pharmaceutica Nv |
New mucoadhesive emulsion compositions and a process for the preparation thereof
|
US7091008B1
(en)
|
1994-07-01 |
2006-08-15 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthase genes and expression thereof in Bacillus hosts
|
US6455304B1
(en)
*
|
1994-07-01 |
2002-09-24 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronate synthase gene and uses thereof
|
IT1273742B
(it)
*
|
1994-08-01 |
1997-07-09 |
Lifegroup Spa |
Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
|
WO1996021432A1
(en)
*
|
1995-01-11 |
1996-07-18 |
Cygnus, Inc. |
Delivery of active substances by way of mucosal surfaces of pharyngeal and esophageal regions
|
EP0812195B1
(de)
*
|
1995-02-28 |
2002-10-30 |
Aventis Pharmaceuticals Inc. |
Arzneizubereitungen für piperidinalkanolderivate
|
US6992107B1
(en)
*
|
1995-03-10 |
2006-01-31 |
Photocure Asa |
Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
|
FR2737661B1
(fr)
*
|
1995-08-08 |
1997-10-31 |
Mgi Pharma Inc |
Composition pharmaceutique sous forme de comprimes comprenant du chlorhydrate de pilocarpine
|
US5741525A
(en)
*
|
1995-10-24 |
1998-04-21 |
Marshall University Research Corporation |
Vaginal pharmaceutical hydrogen peroxide composition
|
DE19600324A1
(de)
*
|
1996-01-08 |
1997-07-10 |
Basf Ag |
Granulate für kosmetische und pharmazeutische Zubereitungen
|
GB2318511A
(en)
*
|
1996-10-23 |
1998-04-29 |
Eurand Int |
Process for the preparation of a pharmaceutical composition for rapid suspension in water
|
DE19646392A1
(de)
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
US6416778B1
(en)
|
1997-01-24 |
2002-07-09 |
Femmepharma |
Pharmaceutical preparations and methods for their regional administration
|
US5993856A
(en)
*
|
1997-01-24 |
1999-11-30 |
Femmepharma |
Pharmaceutical preparations and methods for their administration
|
GB9710699D0
(en)
*
|
1997-05-24 |
1997-07-16 |
Danbiosyst Uk |
Gastro-retentive controlled release system
|
US20020018754A1
(en)
|
1999-03-15 |
2002-02-14 |
Paul Albert Sagel |
Shapes for tooth whitening strips
|
US6582708B1
(en)
|
2000-06-28 |
2003-06-24 |
The Procter & Gamble Company |
Tooth whitening substance
|
US6096328A
(en)
|
1997-06-06 |
2000-08-01 |
The Procter & Gamble Company |
Delivery system for an oral care substance using a strip of material having low flexural stiffness
|
US6572874B1
(en)
*
|
1998-05-15 |
2003-06-03 |
Umd, Inc. |
Vaginal delivery of bisphosphonates
|
PT998272E
(pt)
*
|
1997-08-26 |
2003-09-30 |
Aventis Pharma Inc |
Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
|
CN1322121C
(zh)
*
|
1997-10-31 |
2007-06-20 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
CN101113436B
(zh)
*
|
1997-10-31 |
2013-02-06 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
JPH11269064A
(ja)
*
|
1998-03-20 |
1999-10-05 |
Kowa Co |
胃・十二指腸付着性医薬組成物
|
US20060188966A1
(en)
*
|
1998-04-02 |
2006-08-24 |
Deangelis Paul L |
Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
|
US7060469B2
(en)
*
|
1998-04-02 |
2006-06-13 |
The Board Of Regents Of The University Of Oklahoma |
Polymer grafting by polysaccharide synthases
|
US20080108110A1
(en)
*
|
1998-04-02 |
2008-05-08 |
Deangelis Paul L |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
US6987023B2
(en)
*
|
1998-04-02 |
2006-01-17 |
The Board Of Regents Of The University Of Oklahoma |
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
|
US7223571B2
(en)
*
|
1998-04-02 |
2007-05-29 |
The Board Of Regents Of The Universtiy Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
US7094581B2
(en)
*
|
1998-10-26 |
2006-08-22 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthases and methods of making and using same
|
EP1129209B1
(de)
*
|
1998-11-11 |
2009-01-21 |
The Board Of Regents Of The University Of Oklahoma |
Polymerpfropfung mittels polysaccharide-synthase
|
US6552024B1
(en)
|
1999-01-21 |
2003-04-22 |
Lavipharm Laboratories Inc. |
Compositions and methods for mucosal delivery
|
DE19906152B4
(de)
|
1999-02-10 |
2005-02-10 |
Jenapharm Gmbh & Co. Kg |
Wirkstoffhaltige Laminate für Transdermalsysteme
|
US6159491A
(en)
*
|
1999-02-12 |
2000-12-12 |
Biovector Technologies, Inc. |
Prolonged release bioadhesive vaginal gel dosage form
|
IN191482B
(de)
*
|
1999-03-19 |
2003-12-06 |
Ranbaxy Lab Ltd |
|
US7642071B2
(en)
|
1999-04-01 |
2010-01-05 |
The Board Of Regents Of The University Of Oklahoma |
Methods of expressing gram-negative glycosaminoglycan synthase genes in gram-positive hosts
|
US6297337B1
(en)
|
1999-05-19 |
2001-10-02 |
Pmd Holdings Corp. |
Bioadhesive polymer compositions
|
EP1200064B1
(de)
|
1999-07-02 |
2003-05-02 |
The Procter & Gamble Company |
Zusammensetzungen zur freisetzung von mundpflegewirkstoffen enthaltend organosiloxan harze durch verwendung eines wiederablösbaren trägerstreifens
|
EP1206943B1
(de)
|
1999-08-26 |
2010-04-07 |
Takeda Pharmaceutical Company Limited |
Nasenschleimhaut haftende matrix
|
US7534589B2
(en)
*
|
1999-11-10 |
2009-05-19 |
The Board Of Regents Of The University Of Oklahoma |
Polymer grafting by polysaccharide synthases
|
AU2001234005B2
(en)
*
|
2000-02-28 |
2006-01-19 |
Pharmakodex Limited |
Improvements in or relating to the delivery of oral drugs
|
WO2001068124A2
(en)
|
2000-03-15 |
2001-09-20 |
The Brigham And Women's Hospital, Inc. |
Suppression of vascular disorders by mucosal administration of heat shock protein peptides
|
US20050287638A1
(en)
*
|
2000-04-25 |
2005-12-29 |
Weigel Paul H |
Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
|
US8012504B2
(en)
*
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US6372252B1
(en)
|
2000-04-28 |
2002-04-16 |
Adams Laboratories, Inc. |
Guaifenesin sustained release formulation and tablets
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
US7838032B2
(en)
*
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
US7985420B2
(en)
*
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US7527807B2
(en)
*
|
2000-06-21 |
2009-05-05 |
Cubist Pharmaceuticals, Inc. |
Compositions and methods for increasing the oral absorption of antimicrobials
|
CN1311800C
(zh)
|
2000-06-28 |
2007-04-25 |
宝洁公司 |
提高活性过氧化物的稳定性的结构体和组合物
|
FR2811571B1
(fr)
*
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
GB0018527D0
(en)
*
|
2000-07-27 |
2000-09-13 |
Photocure Asa |
Composition
|
MXPA03004546A
(es)
*
|
2000-11-22 |
2003-09-10 |
Rxkinetix Inc |
Tratamiento de mucositis.
|
US7803392B2
(en)
*
|
2000-12-27 |
2010-09-28 |
University Of Kentucky Research Foundation |
pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
|
DE10107659B4
(de)
*
|
2001-02-19 |
2008-03-13 |
Lts Lohmann Therapie-Systeme Ag |
Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
|
DE10120092B4
(de)
*
|
2001-04-25 |
2008-03-20 |
Lts Lohmann Therapie-Systeme Ag |
Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
|
US20030083286A1
(en)
*
|
2001-08-22 |
2003-05-01 |
Ching-Leou Teng |
Bioadhesive compositions and methods for enhanced intestinal drug absorption
|
US20030124196A1
(en)
|
2001-08-22 |
2003-07-03 |
Susan Weinbach |
Pulsatile release compositions and methods for enhanced intestinal drug absorption
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US7425292B2
(en)
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US7666337B2
(en)
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US7910641B2
(en)
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US8425892B2
(en)
*
|
2001-10-29 |
2013-04-23 |
Columbia Laboratories, Inc. |
Extended, controlled-release pharmaceutical compositions using charged polymers
|
US20030114394A1
(en)
*
|
2001-10-29 |
2003-06-19 |
Levine Howard L. |
Vaginally administered anti-dysrhythmic agents for treating pelvic pain
|
US7709026B2
(en)
*
|
2001-10-29 |
2010-05-04 |
Columbia Laboratories, Inc. |
Low concentration of peroxide for treating or preventing vaginal infections
|
EP1864660B1
(de)
|
2001-11-01 |
2010-12-29 |
Spectrum Pharmaceuticals, Inc. |
Medizinische Zusammensetzungen zur intravesikalen Behandlung von Blasenkrebs
|
US8563592B2
(en)
|
2001-11-01 |
2013-10-22 |
Spectrum Pharmaceuticals, Inc. |
Bladder cancer treatment and methods
|
US20070020737A1
(en)
*
|
2001-12-03 |
2007-01-25 |
Pummill Philip E |
Hyaluronan synthases and methods of making and using same
|
MXPA04006017A
(es)
*
|
2001-12-20 |
2005-06-08 |
Femmepharma Inc |
Suministro de farmacos por via vaginal.
|
WO2003105811A2
(en)
*
|
2002-01-31 |
2003-12-24 |
Southwest Research Institute |
Controlled release compositions and methods for using same
|
BG65734B1
(bg)
*
|
2002-02-22 |
2009-09-30 |
Био Терапютикс - Еоод |
Течен мукоадхезивен фармацевтичен състав
|
US8728510B1
(en)
|
2002-03-15 |
2014-05-20 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible carrier containing a bioadhesive material
|
WO2003084517A2
(fr)
|
2002-04-09 |
2003-10-16 |
Flamel Technologies |
Suspension orale de microcapsules d’amoxicilline
|
PT1492511E
(pt)
|
2002-04-09 |
2009-04-09 |
Flamel Tech Sa |
Formulação farmacêutica oral na forma de suspensão aquosa de microcápsulas para libertação modificada de princípio(s) activo(s)
|
US8017150B2
(en)
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US6949240B2
(en)
|
2002-05-23 |
2005-09-27 |
The Procter & Gamble Company |
Tooth whitening products
|
US8268352B2
(en)
*
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
US8524200B2
(en)
|
2002-09-11 |
2013-09-03 |
The Procter & Gamble Company |
Tooth whitening products
|
US20040115137A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Verrall Andrew P. |
Water-soluble film for oral administration
|
US20040228918A1
(en)
*
|
2003-01-02 |
2004-11-18 |
Chih-Ming Chen |
Granule modulating hydrogel system
|
JP2006515026A
(ja)
*
|
2003-01-02 |
2006-05-18 |
フェムファーマ ホールディング カンパニー, インコーポレイテッド |
乳房の疾患および障害の処置のための薬学的調製物
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
DE10300325A1
(de)
*
|
2003-01-09 |
2004-07-22 |
Hexal Ag |
Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
|
US20050118261A1
(en)
*
|
2003-06-12 |
2005-06-02 |
Oien Hal J. |
Compositions and methods of administering doxepin to mucosal tissue
|
US8157788B2
(en)
*
|
2003-11-06 |
2012-04-17 |
Paolo L. Manfredi |
Multi-site drug delivery platform
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
WO2007001448A2
(en)
*
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
WO2006072946A2
(en)
|
2005-01-04 |
2006-07-13 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
|
WO2006118948A2
(en)
*
|
2005-04-29 |
2006-11-09 |
Cubist Pharmaceuticals, Inc. |
Therapeutic compositions
|
CA2635603C
(en)
*
|
2005-11-30 |
2016-01-19 |
Endo Pharmaceuticals Inc. |
Treatment of xerostomia
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
SE530184C2
(sv)
*
|
2005-12-23 |
2008-03-18 |
Kjell Stenberg |
Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
WO2007133807A2
(en)
*
|
2006-05-15 |
2007-11-22 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
JP5230613B2
(ja)
|
2006-05-23 |
2013-07-10 |
テラコス・インコーポレイテッド |
グルコース輸送体阻害剤およびその使用方法
|
US7893053B2
(en)
|
2006-06-16 |
2011-02-22 |
Theracos, Inc. |
Treating psychological conditions using muscarinic receptor M1 antagonists
|
US8748419B2
(en)
|
2006-06-16 |
2014-06-10 |
Theracos, Inc. |
Treating obesity with muscarinic receptor M1 antagonists
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
EP2063864A4
(de)
|
2006-09-20 |
2012-03-14 |
Monosol Rx Llc |
Verzehrbare wasserlösliche folie mit einem schäumungsreduzierenden geschmacksmittel
|
CA2674078C
(en)
*
|
2006-12-26 |
2012-03-20 |
Femmepharma Holding Company, Inc. |
Topical administration of danazol
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
AU2008232419B2
(en)
|
2007-04-02 |
2013-06-20 |
Theracos, Inc. |
Benzylic glycoside derivatives and methods of use
|
WO2008124634A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
JP2010523595A
(ja)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ(アミノ酸)ターゲッティング部分
|
US20120027855A1
(en)
|
2007-07-06 |
2012-02-02 |
Lupin Limited |
Pharmaceutical compositions for gastrointestinal drug delivery
|
WO2009008006A2
(en)
*
|
2007-07-06 |
2009-01-15 |
Lupin Limited |
Pharmaceutical compositions for gastrointestinal drug delivery
|
EP3620153A1
(de)
|
2007-07-06 |
2020-03-11 |
Lupin Limited |
Pharmazeutische zusammensetzungen zur wirkstoffverabreichung im magen-darm-trakt
|
PL2187742T3
(pl)
|
2007-08-23 |
2018-06-29 |
Theracos Sub, Llc |
Pochodne (2s,3r,4r,5s,6r)-2-(4-chloro-3-benzylofenylo)-6-(hydroksymetylo) tetrahydro-2h-pirano-3,4,5-triolu do stosowania w leczeniu cukrzycy
|
US10736848B2
(en)
|
2007-10-12 |
2020-08-11 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
TWI523652B
(zh)
|
2008-07-15 |
2016-03-01 |
泰瑞克公司 |
氘化苄基苯衍生物及使用方法
|
AR073118A1
(es)
|
2008-08-22 |
2010-10-13 |
Theracos Inc |
Procesos para la preparacion de inhibidores de sglt2 y formas cristalinas del mismo.
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
AU2009324894B2
(en)
|
2008-11-25 |
2015-04-09 |
University Of Rochester |
MLK inhibitors and methods of use
|
US20110003000A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Femmepharma Holding Company, Inc. |
Transvaginal Delivery of Drugs
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
CA2800176C
(en)
|
2010-05-24 |
2018-08-28 |
University Of Rochester |
Bicyclic heteroaryl kinase inhibitors and methods of use
|
US8974826B2
(en)
|
2010-06-10 |
2015-03-10 |
Monosol Rx, Llc |
Nanoparticle film delivery systems
|
WO2011153712A1
(en)
|
2010-06-12 |
2011-12-15 |
Theracos, Inc. |
Crystalline form of benzylbenzene sglt2 inhibitor
|
WO2012048333A1
(en)
|
2010-10-08 |
2012-04-12 |
R.P. Scherer Technologies, Llc |
Oral vaccine fast-dissolving dosage form using starch
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US9592288B2
(en)
|
2011-02-18 |
2017-03-14 |
The Scripps Research Institute |
Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
|
US8524664B2
(en)
|
2011-06-02 |
2013-09-03 |
Colorado Seminary, Which owns and Operates The Univeristy of Denver |
Methods of treating overproduction of cortisol using ACTH antagonist peptides
|
ES2658972T3
(es)
|
2012-06-20 |
2018-03-13 |
University Of Waterloo |
Sistema de administración de nanopartículas mucoadhesivas
|
US9878000B2
(en)
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
US10285915B2
(en)
|
2012-10-17 |
2019-05-14 |
The Procter & Gamble Company |
Strip for the delivery of an oral care active and methods for applying oral care actives
|
WO2014085795A1
(en)
|
2012-11-30 |
2014-06-05 |
University Of Rochester |
Mixed lineage kinase inhibitors for hiv/aids therapies
|
US11278506B2
(en)
|
2015-10-09 |
2022-03-22 |
Rb Health (Us) Llc |
Pharmaceutical formulation
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
EP3452023A1
(de)
|
2016-05-05 |
2019-03-13 |
Aquestive Therapeutics, Inc. |
Epinephrinzusammensetzungen mit verbesserter freisetzung
|
US20200352991A1
(en)
*
|
2017-07-27 |
2020-11-12 |
The Trustees Of Columbia University In The City Of New York |
Polymer films with antimicrobial agents
|